A closer look at the GECKO system following first-in-human study results

1406

Following the presentation of first-in-human cases with the GECKO system at the 2022 European Society of Minimally Invasive Neurological Therapy (ESMINT) congress (7–9 September, Nice, France), Basecamp Vascular (BCV) CEO and co-founder Raphaël Blanc (Foundation Rothschild Hospital, Paris, France) spoke to NeuroNews to discuss this technology. 

In this video, Blanc also outlines potential directions the company may take in the future, and BCV chief technology officer and co-founder Jean-Baptiste Cazeneuve provides a live demonstration with the device—a steerable mechatronic guidewire intended for use in neurovascular stroke treatments.


LEAVE A REPLY

Please enter your comment!
Please enter your name here